RxDoctor Payments DataLook up a doctor →

Kathleen Archer

Family Medicine · Gretna, NENPI 1861482762

Payments from drug & device makers

$9,570in general payments, 2019–2025

Across 752 payments — averaging $12.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$852
  • Amgen$753
  • AstraZeneca$635
  • Novo Nordisk$584
  • Antares Pharma, Inc.$357
  • plus $4K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)210$2,422
Lilly USA, LLC92$852
Amgen57$753
AstraZeneca23$635
Novo Nordisk80$584
Antares Pharma, Inc.28$357
Mannkind Corporation19$296
Aimmune Therapeutics, Inc.6$249
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$248
Axsome Therapeutics, Inc.20$217
Esperion Therapeutics, Inc.16$217
Bayer10$170
Boehringer Ingelheim10$155
Takeda Pharmaceuticals U.S.A., Inc.8$152
Lundbeck LLC7$142
Pfizer8$139
Biohaven Pharmaceuticals, Inc.12$127
Merck8$125
Biohaven Pharmaceutical Holding Company Ltd.18$117
Abbott5$111
GSK7$93
Otsuka America Pharmaceutical, Inc.4$92
Paratek Pharmaceuticals, Inc.6$88
Sanofi-aventis U.S. LLC4$72
Smith+Nephew3$68
Teva Pharmaceuticals USA, Inc.3$64
Mayne Pharma Commercial LLC7$57
Supernus Pharmaceuticals, Inc.2$54
Novartis3$54
Amarin Pharma, Inc.3$52
Arbor Pharmaceuticals, Inc.3$52
Phathom Pharmaceuticals, Inc.7$49
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$48
Madrigal Pharmaceuticals2$46
Tris Pharma Inc2$46
Currax Pharmaceuticals LLC3$44
Jazz Pharmaceuticals Inc.3$41
Exeltis, USA Inc.2$38
Acella Pharmaceuticals, LLC2$34
Tolmar, Inc.2$34
Amneal Pharmaceuticals LLC2$33
Boston Scientific2$33
Silk Road Medical, Inc.1$32
Inspire Medical Systems, Inc.1$30
Astellas Pharma US Inc2$29
Radius Health, Inc.1$25
Vanda Pharmaceuticals Inc.1$22
Hologic Sales And Service, LLC1$22
Lexicon Pharmaceuticals, Inc.1$20
Nestle Healthcare Nutrition Inc.1$20
Actelion Pharmaceuticals US, Inc.1$19
Genentech USA, Inc.1$19
Ardelyx, Inc.1$18
Mylan Specialty L.p.1$18
Avion Pharmaceuticals1$16
Ascensia Diabetes Care US Inc.1$13
Kowa Pharmaceuticals America, Inc.1$13

How this compares

$9,570 in reported general payments places this provider in the 90th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska →

Medicare billing

Part B allowed, 2024
$38,134
Medicare patients
142
Services billed
5,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Gretna

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →